The use of corticosteroids in severe alcohol hepatitis: We need to look beyond this controversy

Journal of Hepatology

Volumn 53, Issue 2, 2010, Pages 392-393

  Mathurin, Philippe ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; PENTOXIFYLLINE;

ALCOHOL LIVER DISEASE; ARTICLE; CORTICOSTEROID THERAPY; DISEASE SEVERITY; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER FUNCTION; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; TREATMENT OUTCOME; ACUTE DISEASE; HEPATITIS, ALCOHOLIC;

ACUTE DISEASE; ADRENAL CORTEX HORMONES; HEPATITIS, ALCOHOLIC; HUMANS; TREATMENT OUTCOME;

EID: 77955309428     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.03.014     Document Type: Note

References (12)

1. A. Rambaldi, H.H. Saconato, E. Christensen, K. Thordlund, J. Wetterslev, and C. Gluud Systematic review: glucocorticosteroids for alcoholic hepatitis - a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials Aliment Pharmacol Ther 27 2008 1167 1178
2. W. Dunn, L.H. Jamil, L.S. Brown, R.H. Wiesner, W.R. Kim, and K.V.N. Menon MELD accurately predicts mortality in patients with alcoholic hepatitis Hepatology 41 2005 353 358
3. W. Srikureja, N.L. Kyulo, B.A. Runyon, and K.Q. Hu Meld is a better prognostic model than Child-Turcotte-Pugh score or discriminant function score in patients with alcoholic hepatitis J Hepatol 42 2005 700 706
4. R.L. Carithers Jr., H.F. Herlong, A.M. Diehl, E.W. Shaw, B. Combes, and H.J. Fallon Methylprednisolone therapy in patients with severe alcoholic hepatitis: a randomized multicenter trial Ann Intern Med 110 1989 685 690
5. M. Phillips, H. Curtis, B. Portmann, N. Donaldson, A. Bomford, and J. O'Grady Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis - a randomised clinical trial J Hepatol 44 2006 784 790
6. P. Mathurin, C. Mendenhall, R.L. Carithers Jr., M.J. Ramond, W.C. Maddrey, and P. Garstide Corticosteroids improve short term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials J Hepatol 36 2002 480 487
7. P. Bories, J.Y. Guedj, D. Mirouze, A. Yousfi, and H. Michel Traitement de l'hépatite alcoolique aiguë par la prednisolone Presse Med 16 1987 769 772 (Pubitemid 17077442)
8. T. Poynard, M. Munteanu, V. Ratziu, Y. Benhamou, V. Di Martino, and J. Taieb Truth survival in clinical research: an evidence based requiem? Ann Intern Med 136 2002 888 895
9. M. Lucey, P. Mathurin, and T.R. Morgan Alcoholic hepatitis N Engl J Med 360 2009 2758 2769
10. A. Louvet, S. Naveau, M. Abdelnour, M.J. Ramond, E. Diaz, and L. Fartoux The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids Hepatology 45 2007 1348 1354
11. P. Mathurin, J. O'Grady, R.L. Carithers, M. Phillips, M.J. Ramond, and A. Louvet Corticosteroids improve 28-day survival in patients with severe alcoholic hepatitis: individual data analysis of the last 5 randomized controlled trials Hepatology 48 2008 170A
12. R.S. O'Shea, S. Dasarathy, and A.J. McCullough Alcoholic liver disease Hepatology 51 2010 307 328